WHO ICTRP trial
A Phase 3 Study of CS-8958 (Prophylaxis for children)
JPRN-jRCT2080222627 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-jRCT2080222627 |
|---|---|
| Public title | A Phase 3 Study of CS-8958 (Prophylaxis for children) |
| Scientific title | A Phase 3 Study of CS-8958 (Prophylaxis for children) - A randomized, double-blind, placebo-controlled study to evaluate the efficacy for the prevention of influenza virus infection in children under 10 years- |
| Primary sponsor | DAIICHI SANKYO CO., LTD. |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 3 |
| Countries | Japan |
| Conditions | Postexposure prophylaxis of influenza A or B virus infection |
| Interventions | investigational material(s) Generic name etc : CS-8958 INN of investigational material : laninamivir Therapeutic category code : 625 Anti-virus agents Dosage and Administration for Investigational material : Single inhaled administration of… |
| Registration date | Oct 16, 2014 |
| Target size | 300 |
| Secondary IDs | JapicCTI-142678 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: